Guardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) Director Steven D. Cosler bought 7,000 shares of the business’s stock in a transaction dated Tuesday, November 19th. The shares were bought at an average cost of $21.22 per share, for a total transaction of $148,540.00. Following the purchase, the director now directly owns 17,713 shares in the company, valued at approximately $375,869.86. This represents a 65.34 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Guardian Pharmacy Services Stock Up 4.6 %
Shares of NYSE GRDN opened at $23.08 on Friday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $23.35.
Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The business had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. Equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on GRDN
Hedge Funds Weigh In On Guardian Pharmacy Services
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $189,000. Virtu Financial LLC bought a new position in shares of Guardian Pharmacy Services during the third quarter valued at approximately $279,000. Barclays PLC bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $311,000. Point72 DIFC Ltd bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $573,000. Finally, Royce & Associates LP bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $1,260,000.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- Earnings Per Share Calculator: How to Calculate EPS
- Tesla Investors Continue to Profit From the Trump Trade
- How to Invest in Biotech Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.